Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 49 articles:
HTML format



Single Articles


    September 2021
  1. EREZ D, Fanadka F, Benchetrit S, Cohen-Hagai K, et al
    The Combined Prognostic Significance of Alkaline Phosphatase and Intracranial Arterial Calcifications in Hemodialysis Patients.
    Am J Nephrol. 2021 Sep 17:1-7. doi: 10.1159/000518399.
    PubMed     Abstract available


  2. THEOFILIS P, Vordoni A, Koukoulaki M, Vlachopanos G, et al
    Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives.
    Am J Nephrol. 2021 Sep 17:1-9. doi: 10.1159/000518456.
    PubMed     Abstract available


  3. CIARDULLO S, Ballabeni C, Trevisan R, Perseghin G, et al
    Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease.
    Am J Nephrol. 2021;52:666-672.
    PubMed     Abstract available


  4. ROY N, Rosas SE
    IL-6 Is Associated with Progression of Coronary Artery Calcification and Mortality in Incident Dialysis Patients.
    Am J Nephrol. 2021 Sep 15:1-8. doi: 10.1159/000518652.
    PubMed     Abstract available


  5. COLOMBIJN JMT, Bonenkamp AA, van Eck van der Sluijs A, Bijlsma JA, et al
    Impact of Polypharmacy on Health-Related Quality of Life in Dialysis Patients.
    Am J Nephrol. 2021 Sep 10:1-10. doi: 10.1159/000518454.
    PubMed     Abstract available


  6. LIU W, Wang L, Li X, Gao C, et al
    C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients.
    Am J Nephrol. 2021 Sep 10:1-10. doi: 10.1159/000518400.
    PubMed     Abstract available


  7. CHALKIA A, Gakiopoulou H, Theohari I, Foukas PG, et al
    Transforming Growth Factor-beta1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease.
    Am J Nephrol. 2021 Sep 8:1-13. doi: 10.1159/000517619.
    PubMed     Abstract available


    July 2021
  8. PERGOLA PE, Belo D, Crawford P, Moustafa M, et al
    Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease.
    Am J Nephrol. 2021 Jul 22:1-10. doi: 10.1159/000516012.
    PubMed     Abstract available


  9. DASHPUTRE AA, Sumida K, Thomas F, Gatwood J, et al
    Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.
    Am J Nephrol. 2021 Jul 21:1-9. doi: 10.1159/000516902.
    PubMed     Abstract available


    June 2021
  10. LIN Z, Liu L, Zhang R, Lin X, et al
    Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology.
    Am J Nephrol. 2021 Jun 16:1-12. doi: 10.1159/000516187.
    PubMed     Abstract available


  11. CHOI YS, Lee HS, Joo N, Park P, et al
    Efficacy and Safety of Plastic Cannulae Compared with Metal Needles in the Initial Use of an Arteriovenous Fistulae in Incident Hemodialysis Patients: A Randomized Controlled Study.
    Am J Nephrol. 2021 Jun 10:1-8. doi: 10.1159/000516212.
    PubMed     Abstract available


  12. SHIGEMATSU T, Une Y, Ikejiri K, Kanda H, et al
    Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
    Am J Nephrol. 2021 Jun 7:1-11. doi: 10.1159/000516156.
    PubMed     Abstract available


    May 2021
  13. BANERJEE T, Carrero JJ, McCulloch C, Burrows NR, et al
    Dietary Factors and Prevention: Risk of End-Stage Kidney Disease by Fruit and Vegetable Consumption.
    Am J Nephrol. 2021 May 27:1-12. doi: 10.1159/000514754.
    PubMed     Abstract available


  14. VODOSEK HOJS N, Ekart R, Bevc S, Piko N, et al
    CHA2DS2-VASc Score as a Predictor of Cardiovascular and All-Cause Mortality in Chronic Kidney Disease Patients.
    Am J Nephrol. 2021 May 11:1-8. doi: 10.1159/000516121.
    PubMed     Abstract available


  15. OZCAN C
    Conduction Intervals and Atrial Fibrillation in Chronic Kidney Disease.
    Am J Nephrol. 2021 May 10:1-2. doi: 10.1159/000516153.
    PubMed    


  16. SUBRAMANIAN N, Han J, Leeper NJ, Ross EG, et al
    Comparison of Pre-Amputation Evaluation in Patients with and without Chronic Kidney Disease.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516017.
    PubMed     Abstract available


  17. LEE HJ, Kwak N, Kim YC, Choi SM, et al
    Impact of Sleep Duration on Mortality and Quality of Life in Chronic Kidney Disease: Results from the 2007-2015 KNHANES.
    Am J Nephrol. 2021 May 6:1-8. doi: 10.1159/000516096.
    PubMed     Abstract available


  18. SCOVNER KM, Correa S, Claggett BL, Barrett CD, et al
    Specific Electrocardiograph Intervals Predict Hospitalization with Atrial Fibrillation in Those with Chronic Kidney Disease.
    Am J Nephrol. 2021 May 5:1-8. doi: 10.1159/000515670.
    PubMed     Abstract available


    April 2021
  19. BOYER A, Lanot A, Lambie M, Verger C, et al
    Trends in Peritoneal Dialysis Technique Survival, Death, and Transfer to Hemodialysis: A Decade of Data from the RDPLF.
    Am J Nephrol. 2021 Apr 27:1-10. doi: 10.1159/000515472.
    PubMed     Abstract available


  20. MURASHIMA M, Hamano T, Abe M, Masakane I, et al
    Encapsulating Peritoneal Sclerosis and Mortality Related to Infection in Patients on Combination Once-Weekly Hemodialysis with Peritoneal Dialysis.
    Am J Nephrol. 2021 Apr 23:1-6. doi: 10.1159/000515150.
    PubMed     Abstract available


  21. TANTISATTAMO E, Murray V, Obi Y, Park C, et al
    Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.
    Am J Nephrol. 2021 Apr 23:1-14. doi: 10.1159/000513855.
    PubMed     Abstract available


  22. WEI KY, Liao CY, Chung CH, Lin FH, et al
    Carbon Monoxide Poisoning and Chronic Kidney Disease Risk: A Nationwide, Population-Based Study.
    Am J Nephrol. 2021 Apr 22:1-12. doi: 10.1159/000515383.
    PubMed     Abstract available


  23. ALI H, Mohamed MM, Sharma A, Fulop T, et al
    Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis.
    Am J Nephrol. 2021 Apr 22:1-13. doi: 10.1159/000514454.
    PubMed     Abstract available


  24. PELLA E, Boutou A, Theodorakopoulou MP, Sarafidis P, et al
    Assessment of Exercise Intolerance in Patients with Pre-Dialysis CKD with Cardiopulmonary Function Testing: Translation to Everyday Practice.
    Am J Nephrol. 2021 Apr 21:1-15. doi: 10.1159/000515384.
    PubMed     Abstract available


  25. NAVARRETE JE, Tong DC, Cobb J, Rahbari-Oskoui FF, et al
    Epidemiology of COVID-19 Infection in Hospitalized End-Stage Kidney Disease Patients in a Predominantly African-American Population.
    Am J Nephrol. 2021 Apr 7:1-9. doi: 10.1159/000514752.
    PubMed     Abstract available


    March 2021
  26. FENG Y, Jones MR, Chu NM, Segev DL, et al
    Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis.
    Am J Nephrol. 2021 Mar 31:1-11. doi: 10.1159/000514233.
    PubMed     Abstract available


  27. MOROMIZATO T, Kohagura K, Tokuyama K, Shiohira Y, et al
    Predictors of Survival in Chronic Hemodialysis Patients: A 10-Year Longitudinal Follow-Up Analysis.
    Am J Nephrol. 2021 Mar 23:1-11. doi: 10.1159/000513951.
    PubMed     Abstract available


  28. THURLOW JS, Joshi M, Yan G, Norris KC, et al
    Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Am J Nephrol. 2021 Mar 22:1-10. doi: 10.1159/000514550.
    PubMed     Abstract available


  29. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    PubMed     Abstract available


  30. KIM AJ, Ro H, Kim H, Chang JH, et al
    Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Am J Nephrol. 2021 Mar 16:1-12. doi: 10.1159/000513663.
    PubMed     Abstract available


    February 2021
  31. PAI AY, Wenziger C, Streja E, Argueta DA, et al
    Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients.
    Am J Nephrol. 2021 Feb 18:1-10. doi: 10.1159/000513381.
    PubMed     Abstract available


  32. JIANG J, Zhang Y, Chen J, Yang X, et al
    Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis.
    Am J Nephrol. 2021 Feb 17:1-9. doi: 10.1159/000512385.
    PubMed     Abstract available


  33. NANGAKU M, Hamano T, Akizawa T, Tsubakihara Y, et al
    Daprodustat Compared with Epoetin Beta Pegol for Anemia in Japanese Patients Not on Dialysis: A 52-Week Randomized Open-Label Phase 3 Trial.
    Am J Nephrol. 2021 Feb 9:1-10. doi: 10.1159/000513103.
    PubMed     Abstract available


  34. SANAI T, Okamura K, Onoue T, Ono T, et al
    Hemodilution Impacts Assessment of Thyroid Status before and after Hemodialysis in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2021;51:988-994.
    PubMed     Abstract available


    January 2021
  35. OLANIRAN KO, Eneanya ND, Zhao SH, Ofsthun NJ, et al
    Mortality and Hospitalizations among Sickle Cell Disease Patients with End-Stage Kidney Disease Initiating Dialysis.
    Am J Nephrol. 2021 Jan 22:1-9. doi: 10.1159/000513012.
    PubMed     Abstract available


  36. PARK HC, Kwon YE, Choi HY, Oh HJ, et al
    Health Insurance Status Is Related to Risk of Mortality and Hospitalization in Korean Maintenance Hemodialysis Patients: A Longitudinal Cohort Study.
    Am J Nephrol. 2021 Jan 13:1-7. doi: 10.1159/000512855.
    PubMed     Abstract available


    October 2020
  37. GOLIGORSKY MS
    NET Formation in Dialysis: A Valuable, albeit Mysterious and Enticing Predictor of Mortality.
    Am J Nephrol. 2020 Oct 26:1-3. doi: 10.1159/000510772.
    PubMed    


  38. EINBINDER Y, Shnaider A, Ghanayem K, Basok A, et al
    Elevated Circulating Cell-Free DNA in Hemodialysis-Treated Patients Is Associated with Increased Mortality.
    Am J Nephrol. 2020 Oct 26:1-9. doi: 10.1159/000510771.
    PubMed     Abstract available


  39. YANG Y, Qin X, Li Y, Yang S, et al
    Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study.
    Am J Nephrol. 2020 Oct 16:1-10. doi: 10.1159/000509258.
    PubMed     Abstract available


    September 2020
  40. MACHHI R, Mandelbrot DA, Al-Qaoud T, Astor BC, et al
    Characteristics and Graft Survival of Kidney Transplant Recipients with Renal Cell Carcinoma.
    Am J Nephrol. 2020 Sep 30:1-9. doi: 10.1159/000510616.
    PubMed     Abstract available


  41. DANESE MD, Lubeck D, Belozeroff V, Lin TC, et al
    Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis Patients.
    Am J Nephrol. 2020 Sep 23:1-8. doi: 10.1159/000510360.
    PubMed     Abstract available


    July 2020
  42. AZIZ F, Ramadorai A, Parajuli S, Garg N, et al
    Obesity: An Independent Predictor of Morbidity and Graft Loss after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 28:1-9. doi: 10.1159/000509105.
    PubMed     Abstract available


  43. HETZ P, Pirklbauer M, Muller S, Posch L, et al
    Prophylactic Ligature of AV Fistula Prevents High Output Heart Failure after Kidney Transplantation.
    Am J Nephrol. 2020 Jul 13:1-9. doi: 10.1159/000508957.
    PubMed     Abstract available


    June 2020
  44. LYU B, Hansen KE, Jorgenson MR, Astor BC, et al
    Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
    Am J Nephrol. 2020 Jun 2:1-9. doi: 10.1159/000507470.
    PubMed     Abstract available


    April 2020
  45. CHU C, Hasan AA, Gaballa MMS, Zeng S, et al
    Endostatin Is an Independent Risk Factor of Graft Loss after Kidney Transplant.
    Am J Nephrol. 2020;51:373-380.
    PubMed     Abstract available


    March 2020
  46. RODAS LM, Ruiz-Ortiz E, Garcia-Herrera A, Pereira A, et al
    IgA Nephropathy Recurrence after Kidney Transplantation: Role of Recipient Age and Human Leukocyte Antigen-B Mismatch.
    Am J Nephrol. 2020 Mar 18:1-9. doi: 10.1159/000506853.
    PubMed     Abstract available


    January 2020
  47. SAEED F, Adams H, Epstein RM
    Matters of Life and Death: Why Do Older Patients Choose Conservative Management?
    Am J Nephrol. 2020;51:35-42.
    PubMed     Abstract available


    October 2019
  48. BAKRIS GL, Agarwal R, Anker SD, Pitt B, et al
    Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
    Am J Nephrol. 2019 Oct 25:1-12. doi: 10.1159/000503713.
    PubMed     Abstract available


  49. FIRTH C, Kaur T, Chakkera H, Zhang N, et al
    Cardiac Troponin T and Right Ventricular Systolic Pressure Predict Cardiovascular and Mortality Risk in Kidney Transplant Candidates.
    Am J Nephrol. 2019 Oct 22:1-10. doi: 10.1159/000503807.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: